BB's Stock Haven

[garza]

FDA, Clinical Trial Calendar Updates: Genzyme (NASDAQ:GENZ), Isis (NASDAQ:ISIS), Osiris (NASDAQ:OSIR), Roche(RHHBY.PK), Watson
(NYSE:WPI)

There are updates to the BioMedReports.com database of over 200 entries included in the FDA and Clinical Trial Calendars.

The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision deadline dates while the Clinical Trial Calendar encompasses pending clinical trial results and pending re-submissions to the FDA for complete response rulings by the agency which require more information before an approval can be granted.


http://biomedreports.com/articles/most-popular/843-fda-clinical-trial-calendar-updates-genzyme-isis-osiris-roche-watson.html